Molthan L, Crawford MN, Tippett P. Enlargement of the Dombrock blood group system: the finding of anti-Dob. Vox Sang 1973;24:382-4.10.1111/j.1423-0410.1973.tb02659.x4691236
Moheng MC, McCarthy P, Pierce SR. Anti-Dob implicated as the cause of a delayed hemolytic transfusion reaction. Transfusion 1985;25:44-6.10.1046/j.1537-2995.1985.25185116501.x3969700
Halverson G, Shanahan E, Santiago I, et al. The first reported case of anti-Dob causing an acute hemolytic transfusion reaction. Vox Sang 1994; 66:206-9.
Strupp A, Cash K, Uehlinger J. Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients. Transfusion 1998;38:1022-5.10.1046/j.1537-2995.1998.38111299056310.x9838931
Shirey RS, Boyd JS, King KE, et al. Assessment of the clinical significance of anti-Dob. Transfusion 1998; 38:1026-9.10.1046/j.1537-2995.1998.38111299056311.x9838932
Gubin AN, Njoroge JM, Wojda U, et al. Identification of the Dombrock blood group glycoprotein as a polymorphic member of the ADP-ribosyltransferase gene family. Blood 2000;96:2621-7.10.1182/blood.V96.7.2621
Reid ME, Rios M, Yazdanbakhsh K. Applications of molecular biology techniques to transfusion medicine. Semin Hematol 2000;37:166-76.10.1016/S0037-1963(00)90041-6